Short Course of Postoperative Hepatitis B Immunoglobulin plus Antivirals Prevents Reinfection of Liver Transplant Recipients.

Background: Hepatitis B immune globulin (HBIG) has been an integral component of prophylaxis against hepatitis B virus (HBV) recurrence in liver transplantation (LT) recipients, but HBIG is costly and inconvenient to administer, prompting consideration of alternative regimens. Methods: In this retrospective cohort, we report on the success of antiviral therapy combined with a short course (in hospital only) HBIG in liver transplant recipients with HBV DNA

http://ift.tt/2oqiPwx